According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

Moderna Inc. said it will reduce annual spending by about $1.5 billion by 2027 as the company continues to cut costs to ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

Moderna (NASDAQ:MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...

COVID - 19: The Company reported $84 million in Spikevax® sales in the first quarter of 2025, which includes $29 million of U.S. sales and $55 million of international sales. As previously reported, ...

The U.S. FDA is planning to require all new vaccines to undergo placebo-controlled trials before approval. Read more here.

After President Trump’s first nominee to lead the Centers for Disease Control and Prevention (CDC) failed to gain traction ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

The Center for Infectious Disease Research and Policy at the University of Minnesota has quietly begun to steer a national ...

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

The Federal Government has said that the country's dependence on importation of critical health commodities such as ...

The US Food and Drug Administration will require all new vaccines go through placebo-controlled studies before they are ...